A. Afonso

Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.

J. Hasford, G. Requena, C. Huerta, 2015, Respiratory medicine.

Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison

G. Requena, P. Souverein, C. Huerta, 2014, Epilepsia.

Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT‐EU project

A. Bate, G. Requena, J. Logie, 2016, Pharmacoepidemiology and drug safety.

Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long‐acting beta2‐agonist use and the risk of myocardial infarction

A. Hoes, O. Klungel, R. Groenwold, 2016, Pharmacoepidemiology and drug safety.

A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

J. Hasford, P. Souverein, R. Reynolds, 2016, European Journal of Clinical Pharmacology.

Time Trends of Period Prevalence Rates of Patients with Inhaled Long-Acting Beta-2-Agonists-Containing Prescriptions: A European Comparative Database Study

J. Hasford, G. Requena, Y. Alvarez, 2015, PloS one.

Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long‐acting beta2‐agonist use and the risk of myocardial infarction

A. Hoes, O. Klungel, R. Groenwold, 2016, Pharmacoepidemiology and drug safety.